Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Vraylar (cariprazine) and Saphris (asenapine) are both atypical antipsychotics used to treat schizophrenia and bipolar disorder, but they have some key differences. Vraylar is taken once a day by mouth, while Saphris is a dissolvable tablet taken under the tongue twice daily. Vraylar is only available as a brand-name medication, whereas Saphris is available as a lower-cost generic. Vraylar (cariprazine) is used for adults only, but Saphris can be used for bipolar disorder in children aged 10 and older. Weight gain is less common with Vraylar compared to Saphris, which often causes weight gain. Additionally, Vraylar has a higher risk of causing uncontrolled muscle movements, while Saphris can cause mouth numbness and requires you to avoid eating or drinking for 10 minutes after taking it.
Asenapine (Saphris) is an atypical antipsychotic. It's used to treat schizophrenia in adults and bipolar I disorder in people ages 10 years and older. It comes as sublingual (under the tongue) tablets in both a brand-name and generic versions. The usual dosage is to dissolve a tablet under the tongue twice a day. Some potential side effects of this medication include sleepiness, trouble sleeping, and movement problems.
•Restlessness (not being able to sit still, up to 11%)
•Dizziness (up to 7%)
•Constipation (up to 7%)
•Vomiting (up to 7%)
•Mouth numbness (up to 7%)
*Note: Side effects listed above were reported by adults with schizophrenia. Similar side effects are seen in adults and children with bipolar disorder.
Warnings of Vraylar vs. Saphris
Common Side Effects for
•Higher risk of death in older adults with dementia-related psychosis
•Suicidal thoughts and behavior
•Neuroleptic malignant syndrome
•High blood sugar, high cholesterol, and weight gain